Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes von Wanner, Christoph, Inzucchi, Silvio E, Lachin, John M, Fitchett, David, von Eynatten, Maximilian, Mattheus, Michaela, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Zinman, Bernard

Volltext

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes von Zinman, Bernard, Wanner, Christoph, Lachin, John M, Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Mattheus, Michaela, Devins, Theresa, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Inzucchi, Silvio E

Volltext

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease von Wanner, Christoph, Lachin, John M, Inzucchi, Silvio E, Fitchett, David, Mattheus, Michaela, George, Jyothis, Woerle, Hans J, Broedl, Uli C, von Eynatten, Maximilian, Zinman, Bernard

Volltext

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial von Fitchett, David, Zinman, Bernard, Wanner, Christoph, Lachin, John M, Hantel, Stefan, Salsali, Afshin, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Inzucchi, Silvio E

Volltext

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis von Benedict, Ralph HB, DeLuca, John, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard

Volltext

Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort von Steel, D. H., Donachie, P. H. J., Aylward, G. W., Laidlaw, D. A., Williamson, T. H., Yorston, D.

Volltext

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort von Williams, Tracy A, PhD, Lenders, Jacques W M, Prof, Mulatero, Paolo, MD, Burrello, Jacopo, MD, Rottenkolber, Marietta, MS, Adolf, Christian, MD, Satoh, Fumitoshi, Prof, Amar, Laurence, MD, Quinkler, Marcus, MD, Deinum, Jaap, MD, Beuschlein, Felix, Prof, Kitamoto, Kanako K, MD, Pham, Uyen, MD, Morimoto, Ryo, MD, Umakoshi, Hironobu, MD, Prejbisz, Aleksander, MD, Kocjan, Tomaz, MD, Naruse, Mitsuhide, Prof, Stowasser, Michael, Prof, Nishikawa, Tetsuo, MD, Young, William F, Prof, Gomez-Sanchez, Celso E, Prof, Funder, John W, Prof, Reincke, Martin, Prof

Volltext

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis von Feys, Peter, Lamers, Ilse, Francis, Gordon, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard

Volltext

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial von Monteiro, Pedro, Bergenstal, Richard M, Toural, Elvira, Inzucchi, Silvio E, Zinman, Bernard, Hantel, Stefan, Kiš, Sanja Giljanovic, Kaspers, Stefan, George, Jyothis T, Fitchett, David

Volltext

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis von Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard

Volltext

Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis von Strober, Lauren, DeLuca, John, Benedict, Ralph HB, Jacobs, Adam, Cohen, Jeffrey A, Chiaravalloti, Nancy, Hudson, Lynn D, Rudick, Richard A, LaRocca, Nicholas G

Volltext

The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial von Neeland, Ian J, Eliasson, Bjorn, Kasai, Takatoshi, Marx, Nikolaus, Zinman, Bernard, Inzucchi, Silvio E, Wanner, Christoph, Zwiener, Isabella, Wojeck, Brian S, Yaggi, Henry K, Johansen, Odd Erik

Volltext

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients von Nissen, Steven E., Lincoff, A. Michael, Brennan, Danielle, Ray, Kausik K., Mason, Denise, Kastelein, John J.P., Thompson, Paul D., Libby, Peter, Cho, Leslie, Plutzky, Jorge, Bays, Harold E., Moriarty, Patrick M., Menon, Venu, Grobbee, Diederick E., Louie, Michael J., Chen, Chien-Feng, Li, Na, Bloedon, LeAnne, Robinson, Paula, Horner, Maggie, Sasiela, William J., McCluskey, Jackie, Davey, Deborah, Fajardo-Campos, Pedro, Petrovic, Predrag, Fedacko, Jan, Zmuda, Witold, Lukyanov, Yury, Nicholls, Stephen J.

Volltext

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy? von Inzucchi, Silvio E., Fitchett, David, Jurišić‐Eržen, Dubravka, Woo, Vincent, Hantel, Stefan, Janista, Christina, Kaspers, Stefan, George, Jyothis T., Zinman, Bernard

Volltext

A core outcome set for future endometriosis research: an international consensus development study von Duffy, JMN, Hirsch, M, Vercoe, M, Abbott, J, Barker, C, Collura, B, Drake, R, Evers, JLH, Hickey, M, Horne, AW, Hull, ML, Kolekar, S, Lensen, S, Johnson, NP, Mahajan, V, Mol, BW, Otter, A‐S, Puscasiu, L, Rodriguez, MB, Rombauts, L, Vail, A, Wang, R, Farquhar, CM, Daniels, Jane P, Lim, Arianne C, Edmonds, Katie, MacLean, Claire E, Appleton, Amy C, Skelton, Sarah, Byrne, Dominic L, White, Rebecca K, Sardo, Margarida, Fowles, Rebecca C, Ata, Baris, Richatd, Sarah A, Puig Ybanez, Casandra C, Peterson, Matthew C, Elms, Jasmin L, Parks, Ann, De Bie Rocks, Bianca L F, Roe, Jodie C, Doran, Ruby, Ceccaroni, Marcello, Ferreira, Ceu A, Dias, Sofia, Pinnington, Tracey, Laupa‐Santiago, Paula, Turner, Marie C, Schreurs, Anneke M F, Baggot, Eleanor, Socolov, Razvan V, Yossry, Menem, Hodges, Tania M, Barbossa, Marina W P, Mures, Târgu, Lytwyn, Tracy L, Egan‐Reid, Sophia E L, Devlin, Susanna C L, Crees, Kira S, Baldwin, Bethany C, Scott, James R, Gravolin, Amy K, Chapman, Errin F, Bartley, Stephanie N, Hamilton, Alicia J, Thorpe, Kirstie J, Carmody, Denise M, Eyeson, Joanna, Davis, Madeleine D, Henry, Jo, Armour, Mike, Cummings, Presley Y F V, Cook, Lisa A

Volltext

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk von Zinman, Bernard, Inzucchi, Silvio E, Lachin, John M, Wanner, Christoph, Fitchett, David, Kohler, Sven, Mattheus, Michaela, Woerle, Hans J, Broedl, Uli C, Johansen, Odd Erik, Albers, Gregory W, Diener, Hans Christoph

Volltext

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data von Goldman, Myla D, LaRocca, Nicholas G, Rudick, Richard A, Hudson, Lynn D, Chin, Peter S, Francis, Gordon S, Jacobs, Adam, Kapoor, Raj, Matthews, Paul M, Mowry, Ellen M, Balcer, Laura J, Panzara, Michael, Phillips, Glenn, Uitdehaag, Bernard M.J, Cohen, Jeffrey A

Volltext

Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease　― Results From EMPA-REG OUTCOME von Kaku, Kohei, Lee, Jisoo, Mattheus, Michaela, Kaspers, Stefan, George, Jyothis, Woerle, Hans-Juergen, on behalf of the EMPA-REG OUTCOME® Investigators

Volltext

Milestones in Surgical Complication Reporting: Clavien-Dindo Classification 20 Years and Comprehensive Complication Index 10 Years von Abbassi, Fariba, Pfister, Matthias, Lucas, Katharina L, Domenghino, Anja, Puhan, Milo A, Clavien, Pierre-Alain

Volltext

Virtual Reality in Stroke Rehabilitation A Meta-Analysis and Implications for Clinicians von SAPOSNIK, Gustavo, LEVIN, Mindy

Volltext